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OBJECTIVES The American College of Cardiology (ACC) established the National Cardiovascular Data
Registry (ACC–NCDR) to provide a uniform and comprehensive database for analysis of
cardiovascular procedures across the country. The initial focus has been the high-volume,
high-profile procedures of diagnostic cardiac catheterization and percutaneous coronary
intervention (PCI).
BACKGROUND Several large-scale multicenter efforts have evaluated diagnostic catheterization and PCI, but
these have been limited by lack of standard definitions and relatively nonuniform data
collection and reporting methods.
METHODS Both clinical and procedural data, and adverse events occurring up to hospital discharge, were
collected and reported according to uniform guidelines using a standard set of 143 data
elements. Datasets were transmitted quarterly to a central facility for quality-control
screening, storage and analysis. This report is based on PCI data collected from January 1,
1998, through September 30, 2000.
RESULTS A total of 139 hospitals submitted data on 146,907 PCI procedures. Of these, 32% (46,615
procedures) were excluded because data did not pass quality-control screening. The remaining
100,292 procedures (68%) were included in the analysis set. Average age was 64  12 years;
34% were women, 26% had diabetes mellitus, 29% had histories of prior myocardial infarction
(MI), 32% had prior PCI and 19% had prior coronary bypass surgery. In 10% the indication
for PCI was acute MI 6 h from onset, while in 52% it was class II to IV or unstable angina.
Only 5% of procedures did not have a class I indication by ACC criteria, but this varied by
hospital from a low of 0 to a high of 38%. A coronary stent was placed in 77% of procedures,
but this varied by hospital from a low of 0 to a high of 97%. The frequencies of in-hospital
Q-wave MI, coronary artery bypass graft surgery and death were 0.4%, 1.9% and 1.4%,
respectively. Mortality varied by hospital from a low of 0 to a high of 4.2%.
CONCLUSIONS This report presents the first data collected and analyzed by the ACC–NCDR. It portrays a
contemporary overview of coronary interventional practices and outcomes, using uniform data
collection and reporting standards. These data reconfirm overall acceptable results that are
consistent with other reported data, but also confirm large variations between individual
institutions. (J Am Coll Cardiol 2002;39:1096–103) © 2002 by the American College of
Cardiology Foundation
Large-scale multicenter data collection efforts have been
used to evaluate cardiovascular procedures (1–6). These
have examined in-hospital and short-term success along
with adverse outcome events, identified variables associated
with higher risks and ultimately have been used to develop
risk-adjusted predictive multivariate models. This work has
been limited somewhat either geographically or by institu-
tional selection. Furthermore, the data elements collected
and their definitions have varied.
To help overcome these limitations, the American Col-
lege of Cardiology (ACC) established the National Cardio-
vascular Data Registry (ACC–NCDR) to provide a uniform
and geographically comprehensive view of cardiovascular
procedures across the country (7). The initial focus has been
on the high-volume, high-profile procedures of diagnostic
cardiac catheterizations and percutaneous coronary inter-
ventions (PCI). This required a parsimonious set of core
data elements with standard definitions, thus providing a
common language for all institutions. A central data repos-
itory was established at Heart House in Bethesda, Mary-
land. Pilot efforts conducted at several institutions helped
launch the effort by collecting data using the new uniform
dataset, identifying and correcting ambiguities and errors
and transmitting data in a standard file format to the
ACC–NCDR. Afterwards, formal data collection began in
earnest, and efforts to recruit hospitals into this voluntary
effort were initiated. This report represents some of the first
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data collected and analyzed by the ACC–NCDR. It por-
trays a contemporary descriptive overview of coronary in-
terventional practices, concentrating on in-hospital out-
comes.
METHODS
Data collection. Hospitals (institutions) performing diag-
nostic cardiac catheterizations and PCI participated volun-
tarily in the ACC–NCDR. Each participating hospital
identified an on-site data manager who supervised data
collection. Patient demographics, clinical history and pro-
cedural information and adverse events that occurred up to
hospital discharge were collected using a standard set of 143
data elements (7). The elements had written definitions and
were gathered using common specifications for all partici-
pants. Data were stored at individual hospitals using com-
mercially available software programs from various vendors
precertified by the ACC–NCDR. These datasets were
transmitted quarterly to the central facility.
Data analysis. Quarterly datasets received at the ACC–
NCDR passed through quality-control checks, identifying
missing or improperly coded items. To be acceptable, each
quarterly submission had to meet quality measures for
accuracy and completeness listed in Table 1. Rejected
quarterly datasets could be resubmitted by an institution
after correction and could then requalify for inclusion if they
passed.
Study data. The current report is based on PCI data
collected from January 1, 1998, through September 30,
2000, representing 11 quarters of dataset submissions.
Demographic, clinical, procedural and outcome variables
were analyzed. Angiographic success for a treated coronary
lesion was defined as 20%-point decrease in diameter
stenosis to a postprocedure value50%, with Thrombolysis
In Myocardial Infarction Trial flow grade 3. Clinical success
was defined as angiographic success at all treated lesions
without death, myocardial infarction (MI) or re-MI or
coronary artery bypass graft surgery (CABG). Patients with
no adverse events were those discharged without death, MI
or CABG, regardless of angiographic success. Urgent or
emergency reintervention was captured as a separate event,
and this did not constitute an adverse outcome unless it
resulted in death, MI or CABG.
Abbreviations and Acronyms
ACC–NCDR  American College of
Cardiology–National Cardiovascular
Data Registry
CABG  coronary artery bypass graft surgery
LOS  length of stay in hospital
MI  myocardial infarction
MVD  multivessel disease
NACI  New Approaches in Coronary
Interventions
NCN  National Cardiovascular Network
NHLBI  National Heart, Lung and Blood
Institute
PCI  percutaneous coronary intervention
SCAI  Society for Cardiac Angiography and
Interventions
Table 1. Inclusion Threshold Criteria
Element Number Element Name
Required at 99%
64 Death in lab (cath procedure)
120 Death in lab (PCI procedure)
141 Death in hospital
Composite required at 90%
5 Patient DOB
6 Patient gender
11 Angina type
12 Angina class
13 Acute or recent MI
21 History of diabetes
22 Diabetic therapy
23 Renal failure
24 Chronic lung disease
26 Peripheral vascular disease
27 Remote MI
28 Hypertension
30 Hypercholesterolemia
32 Same sitting as PCI
50 Dominance
51 Stenosis percent—LM
52 Stenosis percent—Prox LAD
53 Stenosis percent—Other LAD
54 Stenosis percent—RCA
55 Stenosis percent—CIRC
56 Any in-lab complications
68 Coronary lesion in a major artery
70 Significant residual lesion
72 Recurrent coronary stenosis
73 Acute MI present
75 Cardiogenic shock
76 Urgency
78 IABP
79 In-lab thrombolytics
80 In-lab glycoprotein IIb/IIIa blockers
84 Stenosis percent—LM
85 Stenosis percent—Prox LAD
86 Stenosis percent—Other LAD
87 Stenosis percent—RCA
88 Stenosis percent—CIRC
92 Pre-PCI stenosis percent
95 Post-procedure TIMI flow
99 Lesion type
102 Primary treatment device
113 Any in-lab complications
117 In-lab vascular complications
121 Number of lesions attempted
123 Procedure result
129 CABG during this admission
133 Any out-of-lab complications
134 Q-wave MI
139 Vascular complications
CABG  coronary artery bypass graft surgery; CIRC  left circumflex coronary
artery; DOB  date of birth; IABP  intra-aortic balloon pump; LAD  left
anterior descending; LM  left main; MI  myocardial infarction; PCI 
percutaneous coronary intervention; RCA  right coronary artery; TIMI  Throm-
bolysis In Myocardial Infarction.
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Statistics. Continuously distributed variables are shown as
mean  1 SD unless otherwise specified. Categorical
variables are shown by their frequencies in percent. Descrip-
tive variables for acceptable procedures (included group)
were compared to those not included (excluded group).
Remaining analyses were done using only included proce-
dures. Several subgroups of special interest were identified,
and demographic, clinical, procedural and outcome variables
were compared among these subgroups. For all compari-
sons, continuously distributed variables were tested for
differences using unadjusted analysis of variance or t tests,
while categorical variables were tested using chi-square
tests.
RESULTS
There were 146,907 procedures from 139 hospitals submit-
ted during the collection period. One-third of these (46,615
procedures, 32%) were excluded from analysis because
datasets did not pass quality-control screening for the
quarter they were submitted. The remaining two-thirds
(100,292 procedures, 68%) that passed screening criteria
were included. To understand better the effects of the
screening process that excluded what appeared to be a large
proportion of procedures, demographic and clinical charac-
teristics of included and excluded procedures were compared
(Tables 2 and 3). Outcomes for the two groups are shown in
Table 4. There were small differences between included and
excluded procedures for a number of variables, which
because of the large numbers resulted in low p values
according to the statistical tests employed. However, the
major outcome variable of in-hospital mortality was equiv-
alent in the two groups (1.4% vs. 1.3%, p  0.2008, Table
4).
Indications. Class I indications for PCI were examined
and compared to published ACC criteria (8,9). Results are
shown in Table 5. The most common indication for PCI
was the presence of class II to IV angina, either with single
or multivessel coronary disease. Very few patients had only
mild angina. In 10% of procedures, the indication for PCI
was acute MI 6 h from onset. Conversely, class I indica-
tions were not identified for 5% of the procedures. This
varied among individual institutions, from a low of 0 to a
high of 38% without class I indications (Fig. 1).
Clinical features and procedure settings. For procedures
included in the Registry, the frequencies of single, double,
triple and left main disease overall were 41%, 31%, 23% and
5%, respectively (Table 3). At individual hospitals, patients
with multivessel disease (MVD) undergoing PCI ranged
from a low of 4% of procedures to a high of 76% across the
139 institutions. Patients with treatment of a single lesion
ranged only from a low of 37% of procedures to a high of
Table 2. Patient Demographics for Procedures Included and
Excluded From Registry
Included Excluded p Value
No. 100,292 46,615 —
Age (yrs) 64  12 64  14 0.4973
Women 34% 34% 0.4365
Family history of CAD 47% 50% 0.0001
Elevated cholesterol 59% 58% 0.0001
Hypertension 64% 63% 0.0133
Smoking 63% 60% 0.0001
Diabetes 26% 26% 0.4170
Renal disease 3.6% 4% 0.0001
Chronic lung disease 13% 12% 0.0001
Peripheral vascular disease 12.1% 11.6% 0.0056
Prior MI 29% 24% 0.0001
Prior PCI 32% 35% 0.0001
Prior CABG 18.5% 19.3% 0.0002
Clinical syndrome:
Unstable angina 62% 58% 0.0001
Acute MI 6 h 10% 7% 0.0001
CAD  coronary artery disease; other abbreviations as in Table 1.
Table 3. Angiographic and Procedural Characteristics for
Procedures Included and Excluded From Registry
Included
(n  100,292)
Excluded
(n  46,615) p Value
No. of diseased arteries
1 41% 39% 0.0001
2 31% 28% 0.0001
3 23% 24% 0.0001
LM 5% 9% 0.0001
Ejection fraction (%) 53  14 55  14 0.0001
No. of lesions attempted
1 68% 73% 0.0001
2 24% 20% 0.0001
2 8% 7% 0.0001
Primary lesion
LAD 37% 38% 0.1943
LCX 24% 24% 0.7956
RCA 38% 37% 0.2713
LM 1% 1% 0.8625
Stenosis pre-PCI (%) 88  12 87  15 0.0001
Total occlusion pre-PCI 12% 11% 0.0001
Stenosis, post-PCI (%) 6  18 7  19 0.0001
Devices used*
Balloon only 19% 23% 0.0001
Rotablator 1.8% 1.8% 0.8769
Stent 71% 66% 0.0001
Rotablator  stent 2.2% 2% 0.0056
Other 6% 7% 0.0001
*For Rotablator and stent, adjunctive balloon also possible as component of procedure.
Abbreviations as in Table 1.
Table 4. Outcomes of Procedures Included and Excluded
From Registry
Included
(n  100,292)
Excluded
(n  46,615) p Value
Dissection 5% 6% 0.0001
Abrupt closure 1.9% 2% 0.0855
Successful reopening 41% 47% 0.0004
Angiographic success 94.5% 93.5% 0.0001
Post-PCI MI 0.4% 0.3% 0.0032
CABG 1.9% 3.1% 0.0001
Death 1.4% 1.3% 0.2008
Clinical success 92.2% 91.3% 0.0001
No adverse events 96.5% 95.7% 0.0001
Abbreviations as in Table 1.
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94%. Hospital outcomes by clinical presentation (Stable
Angina, Unstable Angina, Acute MI) and procedure setting
(Elective, Urgent, Emergency) are shown in Table 6. Both
acute MI presentation and categorization as an emergency
procedure were associated with lower success rates.
Devices. Success and complication rates by types of devices
used are shown in Table 7. The majority of lesions were
treated with a stent (71% of lesions, 77% of procedures).
However, stent usage ranged from a low of none to a high
of 97% of procedures across the 139 hospitals (Fig. 2).
Clinical subgroups. Three subgroups considered to be of
special clinical interest were identified (Table 8). These were
women compared to men, single-vessel disease patients
compared to MVD, and diabetics compared to nondiabet-
ics. Angiographic success rates were slightly higher for
women than for men, whereas in-hospital mortality for
women was 50% higher than for men (2.0% vs. 1.2%, p 
0.0001). Across the 139 included hospitals, mortality rates
in women varied from 0 to 8.0% (Fig. 3A). Patients with
MVD had lower angiographic and clinical success rates than
single-vessel disease patients. Mortality in MVD patients
overall was 1.8%, but varied from 0 to 9.1% across hospitals
(Fig. 3B). Patients with diabetes had lower success rates
than nondiabetics. Mortality in diabetics overall was 1.8%,
but varied from 0 to 9% across hospitals (Fig. 3C). How-
ever, the overall very high angiographic and clinical success
rates and low complication rates in these three subgroups
are noteworthy.
DISCUSSION
Percutaneous coronary interventions have undergone tre-
mendous growth over the past two decades, driven in part
by numerous technological improvements and much better
adjunctive drug regimens. Assessing the utility and proper
application of these innovations typically is performed in
academic and investigative centers under the guidance of the
most experienced interventional cardiologists. Procedural
success and complication rates after adoption in more
widespread clinical practice have been less well studied.
Controversies have existed in the past over the appropriate
use (both underuse as well as overuse) of PCI in general in
the management of coronary disease (10); more specifically,
questions have arisen among the cardiology community
about clinical outcomes in certain settings like acute MI,
women, diabetic patients and the elderly. The high-profile
visibility of PCI, its resource demands and its potential for
morbidity and mortality clearly identify interventional car-
diology as a logical place to begin national efforts within the
cardiology community to examine performance measures
and outcomes.
Additionally, it has been noted that there are wide
regional variations both in utilization rates and clinical
outcomes with PCI, both in general and for populations
defined by gender, age or insurance status (11). As an
example, it is interesting to note that widespread variation
existed in the proportion of patients at each hospital who
fulfilled ACC class I criteria for undergoing PCI. The ACC
leadership recognizes that one major challenge is under-
standing the sources and reasons for such regional variations
(12). These may represent clinical differences in popula-
tions, differing availability of resources, personal preferences
Table 5. Class I Indications for Procedure by ACC Criteria
Indication
Frequency
(%)
Single-vessel disease, asymptomatic or class I angina 5
Single-vessel disease, class II to IV or unstable angina 21
Multivessel disease, asymptomatic or class I angina 7
Multivessel disease, class II to IV or unstable angina 31
MI 6 h 10
MI 6 h or post-MI, with angina, ischemia or arrhythmia 21
No class I indications identified 5
ACC  American College of Cardiology; MI  myocardial infarction.
Figure 1. Variation in proportion of procedures without class I indications for percutaneous coronary intervention for 139 institutions participating in
American College of Cardiology–National Cardiovascular Data Registry. Data are arranged from lowest to highest proportion. The dashed line represents
overall average of 5%.
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on the part of patients, personal practice styles of physicians
or other factors. Our analysis here was not designed to test
hypotheses or draw conclusions about this observation, and
much more research will be required to understand these
differences fully.
Data quality. Maintaining high data-quality standards is
vital to the success of any national registry. Unacceptable
datasets received at the ACC–NCDR are returned to
institutions for review, allowing the opportunity for correc-
tion and resubmission. Of the procedures submitted during
the study period of 1998 to 2000, one-third (32%) were
excluded from analysis for quality-control reasons. Compar-
ing data from included and excluded procedures suggests
that this likely did not bias results.
Clinical characteristics. The clinical and procedural char-
acteristics of patients reported here, as well as the in-
hospital outcomes, appear very similar to other large-scale
reports covering approximately the same time frame. The
Society for Cardiac Angiography and Interventions (SCAI)
(3), the National Cardiovascular Network (NCN) (4), the
New Approaches in Coronary Interventions (NACI) Reg-
istry (5), and the National Heart, Lung and Blood Institute
(NHLBI) Dynamic Registry (6) noted similar age ranges
for patients, and similar frequencies of women, diabetics,
presence of MVD and intervention for acute MI or unstable
angina. The frequency of in-hospital death was 1.4% in our
series, and 0.5%, 1.3%, 1.6% and 1.9% in the SCAI, NCN,
NACI and NHLBI series, respectively. Likewise, the fre-
quency of same-admission CABG was 1.9% in our series,
and 0.5%, 1.7%, 3.4% and 1.5% in the other four series,
respectively. Stents were the most common coronary device
used in PCI, with a frequency of 71%. Stent usage was 63%
and 64% in the SCAI and NHLBI registries, respectively,
but was somewhat lower at 38% in the NCN registry. These
reports do not indicate the variation in stent usage among
participating institutions. The Dartmouth Atlas of Cardio-
vascular Health Care (11) reported that stents were used
overall in 58% of PCI procedures in 1997, with a fourfold
Table 6. Hospital Outcomes by Clinical Presentation and Procedure Setting
Clinical Presentation
p
Value*
Stable Angina†
(n  32,516)
Unstable Angina
(n  53,386)
Acute MI
(n  10,037)
Angiographic success 94.2% 94.5% 93.7% 0.0010
Post-PCI MI 0.4% 0.5% 0.6% 0.0055
CABG 1.4% 1.7% 4.5%  0.0001
Death 1.1% 1.0% 5.2%  0.0001
No adverse events 97.4% 97.1% 90.4%  0.0001
LOS, days (mean) 1.7 2.3 4.5  0.0001
Procedure Setting
Elective
(n  54,529)
Urgent
(n  27,301)
Emergency
(n  14,109)
p
Value‡
Angiographic success 94.8% 94.4% 92.3%  0.0001
Post-PCI MI 0.3% 0.5% 0.8%  0.0001
CABG 1.2% 1.5% 5.2%  0.0001
Death 0.4% 0.9% 6.4%  0.0001
No adverse events 98.2% 97.3% 88.6%  0.0001
LOS, days (mean) 2.1 2.4 4.9  0.0001
*p Value for comparison of Clinical Presentation as either Stable Angina, Unstable Angina or Acute MI. †Excludes patients with
no symptoms or atypical chest pain. ‡p Value for comparison of Procedure Setting as either Elective, Urgent or Emergency.
LOS  length of stay in hospital; other abbreviations as in Table 1.
Table 7. Success and Complication Rates by Device Use
Balloon
Only Rotablator Stent
Rotablator
 Stent
Other
Devices p Value*
Per lesion
No. of lesions 25,900 2,554 99,294 3,058 7,865 —
Angiographic success 82.0% 96.0% 97.1% 97.4% 91.2%  0.0001
Per procedure
No. of procedures 11,570 1,463 71,341 2,557 9,008 —
Angiographic success 81.9% 96.2% 97.2% 97.6% 85.7%  0.0001
Post-PCI MI 0.6% 0.2% 0.4% 0.9% 0.6%  0.0001
CABG 6.5% 0.8% 1.0% 1.1% 3.3%  0.0001
Death 2.7% 0.6% 1.3% 1.2% 1.5%  0.0001
No adverse events 91.0% 98.5% 97.6% 97.3% 94.9%  0.0001
LOS, days (mean) 3.2 1.9 2.5 2.1 2.7  0.0001
*p Value for comparison of five categories of devices.
Abbreviations as in Table 1.
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variation (from 20% to 80%) across the geographic
regions of the U.S. We noted that stent usage varied widely
between institutions submitting data. The reasons for this
are unknown but clearly deserve further attention in the
future.
Mortality variation. Substantial variations existed between
hospitals for several important clinical subgroups. The
unadjusted mortality rates by institution varied from none to
4.2%, with an overall average of 1.4%. Unadjusted mortality
in certain subgroups of interest (women, MVD, diabetics)
also varied greatly among hospitals. Our descriptive study
was not designed to test hypotheses about this. Risk-
adjusted mortality is the subject of a companion study.
Future research will concentrate on understanding the
sources of these mortality variations more fully.
Conclusions. This report presents the initial results of a
large-scale national effort to bring more uniform and bal-
anced analysis to interventional cardiology. The data re-
ported here represent a contemporary overview of PCIs.
The ACC has been increasing its attention and resources on
assessing the implementation of clinical guidelines into
clinical practice, along with taking the lead in the cardiology
community for developing performance measures and out-
come standards in cardiovascular diseases. The ACC–
NCDR is a superb tool that allows hospitals and clinicians
to examine clinical practices and outcomes in PCI volun-
tarily. We have reconfirmed, using uniform definitions and
standardized reporting, that overall success rates are high,
but wide variations continue to exist in many clinical
features of PCI practice as well as outcomes. We anticipate
continued contributions from the ACC–NCDR in under-
standing these differences, and ultimately further improving
the quality of cardiovascular care for our patients.
Acknowledgments
The authors and the ACC-NCDR Oversight and Planning
Task Force thank the members of the Publications and
Development Subcommittee: Ben D. McCallister, MD;
Charles R. McKay, MD; David O. Williams, MD; H.
Vernon Anderson, MD; John F. Williams, Jr., MD; Leslee
J. Shaw, PhD; Lloyd W. Klein, MD; Martha J. Radford,
MD; Michael A. Kutcher, MD; Michael J. Wolk, MD;
Peter C. Block, MD; Ralph G. Brindis, MD, MPH;
Raymond J. Gibbons, MD; Richard E. Shaw, PhD; Ronald
J. Krone, MD; Ronald N. Riner, MD; Ross A. Davies,
MD; William S. Weintraub, MD.
Figure 2. Variation in proportion of procedures in which coronary stents were placed for 139 institutions participating in American College of
Cardiology–National Cardiovascular Data Registry. Data are arranged from lowest to highest proportion. The dashed line represents overall average of 77%
of procedures.
Table 8. Success and Length of Hospital Stay for Selected Clinical Subgroups
Angiographic
Success
Post-PCI
MI CABG Death
No Adverse
Events
LOS
(Days, Mean)
Men 94.1% 0.4% 1.8% 1.2% 96.8% 2.3
Women 94.6% 0.5% 1.9% 2.0% 96.0% 2.8
p Value 0.0047 0.0145 0.2788 0.0001 0.0001 0.0001
SVD 95.6% 0.3% 1.0% 0.9% 97.9% 2.3
MVD 93.5% 0.5% 2.4% 1.8% 95.7% 2.7
p Value 0.0001 0.0002 0.0001 0.0001 0.0001 0.0001
Diabetic 94.2% 0.4% 1.8% 1.8% 96.2% 2.7
Nondiabetic 94.3% 0.4% 1.9% 1.3% 96.6% 2.4
p Value 0.4309 0.9114 0.4215 0.0001 0.0009 0.0001
MVD  multivessel disease; SVD  single vessel disease; other abbreviations as in Table 6.
1101JACC Vol. 39, No. 7, 2002 Anderson et al.
April 3, 2002:1096–103 A Contemporary Overview of PCI
The authors acknowledge the technical assistance pro-
vided by Jim Emlet, MS in the preparation of the data
analyzed.
Reprint requests and correspondence: Dr. H. Vernon Ander-
son, Texas Heart Institute and the University of Texas, 6431
Fannin, Suite 1246, Houston, Texas 77030. E-mail: h.v.anderson@
uth.tmc.edu.
REFERENCES
1. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-
outcome relationships for hospitals and cardiologists. JAMA 1997;
279:892–8.
2. Malenka DJ, McGrath PD, Wennberg DE, et al. The relationship
between operator volume and outcomes after percutaneous coronary
interventions in high volume hospitals in 1994–1996. J Am Coll
Cardiol 1999;34:1471–80.
3. Laskey WK, Kimmel S, Krone RJ. Contemporary trends in coronary
intervention: a report from the Registry of the Society for Cardiac
Figure 3. Variations in mortality for 139 institutions participating in American College of Cardiology–National Cardiovascular Data Registry, arranged
from lowest to highest for each group: (A) females; (B) patients with multivessel disease; (C) diabetics. The dashed lines on each graph represent overall
average for the group (see text for details).
1102 Anderson et al. JACC Vol. 39, No. 7, 2002
A Contemporary Overview of PCI April 3, 2002:1096–103
Angiography and Interventions. Cathet Cardiovasc Intervent 2000;49:
19–22.
4. Peterson ED, Lansky AJ, Anstrom KJ, et al. Evolving trends in
interventional device use and outcomes: results from the National
Cardiovascular Network database. Am Heart J 2000;139:198 –207.
5. Marks DS, Mensah GA, Kennard ED, Detre K, Holmes DR. Race,
baseline characteristics, and clinical outcomes after coronary interven-
tion: the New Approaches in Coronary Interventions (NACI) registry.
Am Heart J 2000;140:162–9.
6. Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary
intervention in the current era compared with 1985–1986: the Na-
tional Heart, Lung, and Blood Institute Registries. Circulation 2000;
102:2945–51.
7. Weintraub WS, McKay CR, Riner RN, et al. The American College
of Cardiology National Database: progress and challenges. J Am Coll
Cardiol 1997;29:459–65.
8. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percuta-
neous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22:
2033–54.
9. Smith SC, Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for
percutaneous coronary intervention: a report of the American College of
Cardiology/American Heart Association Task Force on Guidelines
(Committee to Revise the 1993 Guidelines for Percutaneous Translumi-
nal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2215–38.
10. Hemingway H, Crook AM, Feder G, et al. Underuse of coro-
nary revascularization procedures in patients considered appropri-
ate candidates for revascularization. N Engl J Med 2001;344:645–
65.
11. Birkmeyer NJO, Lucas FL, Malenka DJ, et al. Birkmeyer JD, ed. The
Dartmouth Atlas of Cardiovascular Health Care. Chicago, IL: AHA
Press, 1999:78.
12. Beller GA. President’s page: geographic variations in delivery of
cardiovascular care: an issue of great importance to cardiovascular
specialists. J Am Coll Cardiol 2000;36:652–5.
1103JACC Vol. 39, No. 7, 2002 Anderson et al.
April 3, 2002:1096–103 A Contemporary Overview of PCI
